221 related articles for article (PubMed ID: 37899480)
1. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology.
Che WQ; Li YJ; Tsang CK; Wang YJ; Chen Z; Wang XY; Xu AD; Lyu J
Mil Med Res; 2023 Oct; 10(1):50. PubMed ID: 37899480
[TBL] [Abstract][Full Text] [Related]
2. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview.
Scosyrev E; Messing J; Noyes K; Veazie P; Messing E
Urol Oncol; 2012; 30(2):126-32. PubMed ID: 20363162
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
4. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
5. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
7. Is the Number of National Database Research Studies in Musculoskeletal Sarcoma Increasing, and Are These Studies Reliable?
Lawrenz JM; Johnson SR; Hajdu KS; Chi A; Bendfeldt GA; Kang H; Halpern JL; Holt GE; Schwartz HS
Clin Orthop Relat Res; 2023 Mar; 481(3):491-508. PubMed ID: 35767810
[TBL] [Abstract][Full Text] [Related]
8. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.
Duggan MA; Anderson WF; Altekruse S; Penberthy L; Sherman ME
Am J Surg Pathol; 2016 Dec; 40(12):e94-e102. PubMed ID: 27740970
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
[TBL] [Abstract][Full Text] [Related]
10. An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.
Tran Q; Warren JL; Barrett MJ; Annett D; Marth M; Cress RD; Deapen D; Glaser SL; Gomez SL; Schwartz SM; Li CI; Wu XC; Enewold L; Harlan LC; Rivera DR; Winn DM; Penberthy L; Cronin KA
J Natl Cancer Inst Monogr; 2020 May; 2020(55):72-81. PubMed ID: 32412073
[TBL] [Abstract][Full Text] [Related]
11. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
12. The "Classification Pendulum" of Stage I Colorectal Cancer: A National Level Analysis of the Survival Difference Between T1 and T2 Colorectal Cancer.
Allievi N; Goffredo P; Freischlag KW; Utria AF; Cromwell JW; Pisano M; Poiasina E; Hassan I
Dis Colon Rectum; 2022 Apr; 65(4):505-518. PubMed ID: 34310516
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.
Groome PA; O'Sullivan B; Irish JC; Rothwell DM; Schulze K; Warde PR; Schneider KM; Mackenzie RG; Hodson DI; Hammond JA; Gulavita SP; Eapen LJ; Dixon PF; Bissett RJ; Mackillop WJ
J Clin Oncol; 2003 Feb; 21(3):496-505. PubMed ID: 12560441
[TBL] [Abstract][Full Text] [Related]
14. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
[TBL] [Abstract][Full Text] [Related]
15. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?
Merrill RM; Dearden KA
Cancer Causes Control; 2004 Dec; 15(10):1027-34. PubMed ID: 15801487
[TBL] [Abstract][Full Text] [Related]
16. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
17. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
Mettlin CJ; Menck HR; Winchester DP; Murphy GP
Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
[TBL] [Abstract][Full Text] [Related]
18. Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract][Full Text] [Related]
19. Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.
Wilson RJ; O'Neil ME; Ntekop E; Zhang K; Ren Y
J Registry Manag; 2014; 41(2):65-71; quiz 96-7. PubMed ID: 25153011
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
